08 October 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

08 October 2018 | n=25

  1. Molina-Leyva A, Badiola J.
    Severe refractory hidradenitis suppurativa successfully treated with adalimumab in an HIV-positive/hepatitis C virus-positive patient.
    AIDS 2018;32:2436-2438.

  2. Gaillet A, Calin R, Imbert S, Ollivier M, et al.
    Distinct paradoxical inflammatory reaction followed by postantiretroviral therapy immune reconstitution syndrome in cryptococcal meningitis.
    AIDS 2018;32:2434-2436.

  3. Schim van der Loeff MF.
    Secondary anal cancer prevention in the HIV-infected: a step ahead but a long way to go.
    AIDS 2018;32:2425-2427.

  4. Rockstroh JK, Gonzalez-Scarano F.
    Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?
    AIDS 2018;32:2423-2424.

  5. Botha J, Conradie F, Etheredge H, Fabian J, et al.
    Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options.
    AIDS 2018;32:F13-F19.

  6. Grant PM, Li X, Jacobson L, Palella FJ, et al.
    Effect of Testosterone Use on Bone Mineral Density in HIV-infected Men.
    AIDS Res Hum Retroviruses 2018.

  7. Havens PL, Tamhane A, Stephensen C, Schuster GU, et al.
    Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses 2018.

  8. Vatsalya V, Cave M, Kumar R, Srivastava S, et al.
    Alterations in serum zinc and polyunsaturated fatty acid concentrations in treatment naive HIV-diagnosed alcohol dependent subjects with liver injury.
    AIDS Res Hum Retroviruses 2018.

  9. Revolinski SL, Munoz-Price LS.
    Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.
    Clin Infect Dis 2018.

  10. Bretana N, Gray R, Law M, Guy R, et al.
    Aging of the HIV Population in Australia: A modeling study.
    J Acquir Immune Defic Syndr 2018.

  11. Dandachi D, May SB, Davila JA, Cully JY, et al.
    The Association of Unmet Needs with Subsequent Retention in Care and HIV Suppression Among Hospitalized Patients with HIV Who Are Out of Care.
    J Acquir Immune Defic Syndr 2018.

  12. Mansergh G, Baack BN, Holman J, Mimiaga MJ, et al.
    Quantitative assessment of brief messages about HIV pre-exposure prophylaxis among HIV-infected and HIV-uninfected black/African American and Hispanic/Latino MSM.
    J Acquir Immune Defic Syndr 2018.

  13. Colie C, Michel KG, Massad LS, Wang MC, et al.
    Natural history of cervical intraepithelial neoplasia-2 in HIV-positive women of reproductive age.
    J Acquir Immune Defic Syndr 2018.

  14. Carrico AW, Hunt PW, Neilands TB, Dilworth SE, et al.
    Stimulant Use and Viral Suppression In the Era of Universal Antiretroviral Therapy.
    J Acquir Immune Defic Syndr 2018.

  15. Obimbo MM, Zhou Y, Mcmaster MT, Cohen CR, et al.
    Placental structure in preterm birth amongst HIV positive versus negative women in Kenya.
    J Acquir Immune Defic Syndr 2018.

  16. Refugio ON, Kimble MM, Silva CL, Lykens JE, et al.
    PrEPTECH: a telehealth-based initiation program for human immunodeficiency virus pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility.
    J Acquir Immune Defic Syndr 2018.

  17. Chang AY, Haber N, Barnighausen T, Herbst K, et al.
    Improving the validity of mathematical models for HIV elimination by incorporating empirical estimates of progression through the HIV treatment cascade.
    J Acquir Immune Defic Syndr 2018.

  18. Hakkers CS, Arends JE, van den Berk GE, Ensing MHM, et al.
    Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr 2018.

  19. Turan B, Crockett KB, Kempf MC, Konkle-Parker D, et al.
    Internal Working Models of Attachment Relationships and HIV Outcomes among Women Living with HIV.
    J Acquir Immune Defic Syndr 2018.

  20. Dadabhai S, Gadama Fcog L, Chamanga R, Kawalazira R, et al.
    Pregnancy outcomes in the era of universal antiretroviral treatment in sub-Saharan Africa (POISE Study).
    J Acquir Immune Defic Syndr 2018.

  21. Chand HS, Vazquez-Guillamet R, Royer CM, Rudolph K, et al.
    Cigarette smoke and HIV synergistically affect lung pathology in cynomolgus macaques.
    J Clin Invest 2018.

  22. Karamouzian M, Kerr T.
    A public health approach to opioid addiction in North America.
    Lancet 2018;391:201-202.

  23. Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, et al.
    Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med 2018.

  24. Bartlett AW, Mohamed TJ, Sudjaritruk T, Kurniati N, et al.
    Disease- and Treatment-Related Morbidity in Adolescents With Perinatal HIV Infection in Asia.
    Pediatr Infect Dis J 2018.

  25. Connolly S, Wall KM, Tang J, Yu T, et al.
    Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.
    Virology 2018;525:132-142.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

20 May 2019

13 May 2019

06 May 2019

29 April 2019

22 April 2019

08 October 2018

Multidisciplinary Journal Club

  1. Mendoza P, Gruell H, Nogueira L, Pai JA, et al.
    Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
    Nature. 2018;561:479-484.

  2. Rothwell PM, Cook NR, Gaziano JM, Price JF, et al.
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.

  3. Harris PNA, Tambyah PA, Lye DC, Mo Y, et al.
    Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    JAMA. 2018;320:984-994.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016